Long-term outcomes of parenchyma-sparing and oncologic resections in patients with nonfunctional pancreatic neuroendocrine tumors< 3 cm in a large multicenter …
L Bolm, M Nebbia, AC Wei, AH Zureikat… - Annals of …, 2022 - journals.lww.com
Methods: Retrospective review of prospectively collected clinicopathologic data of patients
who underwent pancreatectomy between 2000 and 2021 was collected from 4 high-volume …
who underwent pancreatectomy between 2000 and 2021 was collected from 4 high-volume …
Pancreatic fistula after pancreaticoduodenectomy: Risk factors and preventive strategies
JS Chen, G Liu, TR Li, JY Chen, QM Xu… - Journal of cancer …, 2019 - journals.lww.com
Purpose: Postoperative pancreatic fistula (POPF) after pancreaticoduodenectomy (PD) is a
worrisome and life-threatening complication. This study aimed to investigate the risk factors …
worrisome and life-threatening complication. This study aimed to investigate the risk factors …
Robotic enucleation for benign or borderline tumours of the pancreas: a retrospective analysis and comparison from a high‐volume centre in Asia
JB Jin, K Qin, H Li, ZC Wu, Q Zhan… - World journal of …, 2016 - Wiley Online Library
Background Enucleation is increasingly performed for benign or borderline tumours of the
pancreas because it is a parenchyma‐sparing and less invasive procedure compared to …
pancreas because it is a parenchyma‐sparing and less invasive procedure compared to …
Pancreatic stump closure after pancreatoduodenectomy in elderly patients: a retrospective clinical study
C Mauriello, A Polistena, C Gambardella… - Aging clinical and …, 2017 - Springer
Background Pancreatic fistula (PF) after pancreatoduodenectomy (PD) represents the major
source of morbidity. Derivative procedures are preferred by pancreatic surgeons, but the …
source of morbidity. Derivative procedures are preferred by pancreatic surgeons, but the …
Maximum value on arterial phase computed tomography predicts prognosis and treatment efficacy of sunitinib for pancreatic neuroendocrine tumours
H Chen, Z Li, Y Hu, X Xu, Z Ye, X Lou, W Zhang… - Annals of Surgical …, 2023 - Springer
Purpose This study was designed to assess the computed tomography maximum (CTmax)
value on pretherapeutic arterial phase computed tomography (APCT) images to predict …
value on pretherapeutic arterial phase computed tomography (APCT) images to predict …
Surgical resection of a primary tumor improves survival of metastatic pancreatic cancer: a population-based study
L Tao, C Yuan, Z Ma, B Jiang, D Xiu - Cancer management and …, 2017 - Taylor & Francis
Introduction Pancreatic cancer is a lethal disease with a very poor prognosis. This study
investigates survival of patients diagnosed with metastatic pancreatic cancer (mPC) based …
investigates survival of patients diagnosed with metastatic pancreatic cancer (mPC) based …
The prognostic impact of primary tumor resection in pancreatic neuroendocrine tumors with synchronous multifocal liver metastases
C Lin, H Dai, X Hong, H Pang, X Wang, P Xu, J Jiang… - Pancreatology, 2018 - Elsevier
Background Whether primary tumor resection benefits patients with synchronous multifocal
liver metastases from pancreatic neuroendocrine tumors remains controversial. We …
liver metastases from pancreatic neuroendocrine tumors remains controversial. We …
Outcomes of pancreaticoduodenectomy for pancreatic neuroendocrine tumors: are combined procedures justified?
Efficacy and outcomes of resection for pancreatic neuroendocrine tumors (pNET) are well
established; specific data on outcomes for pancreaticoduodenectomy (PD), either alone or …
established; specific data on outcomes for pancreaticoduodenectomy (PD), either alone or …
Identifying prognostic factors for well-differentiated metastatic pancreatic neuroendocrine tumours: a retrospective international multicentre cohort study
P Jiménez-Fonseca, S Krug, G Tamagno… - …, 2019 - karger.com
Pancreatic neuroendocrine tumours (pNETs) represent rare neoplasms of all NETs often
presenting without functional activity. Many sporadic non-functioning pNET patients are …
presenting without functional activity. Many sporadic non-functioning pNET patients are …
[HTML][HTML] Pancreatic neuroendocrine tumors in the 21st century—an update
Pancreatic neuroendocrine tumors (PNETs) are rare, reported to account for less than 1%-
2% of all pancreatic tumors. This, however, is likely an underestimation, as improved …
2% of all pancreatic tumors. This, however, is likely an underestimation, as improved …